Correlation Between Champions Oncology and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Purple Biotech, you can compare the effects of market volatilities on Champions Oncology and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Purple Biotech.
Diversification Opportunities for Champions Oncology and Purple Biotech
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Champions and Purple is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Champions Oncology i.e., Champions Oncology and Purple Biotech go up and down completely randomly.
Pair Corralation between Champions Oncology and Purple Biotech
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.45 times more return on investment than Purple Biotech. However, Champions Oncology is 2.22 times less risky than Purple Biotech. It trades about 0.08 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.03 per unit of risk. If you would invest 398.00 in Champions Oncology on August 28, 2024 and sell it today you would earn a total of 20.00 from holding Champions Oncology or generate 5.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Purple Biotech
Performance |
| Timeline |
| Champions Oncology |
| Purple Biotech |
Champions Oncology and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Purple Biotech
The main advantage of trading using opposite Champions Oncology and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |